Literature DB >> 2166555

Patients with n-hexane induced polyneuropathy: a clinical follow up.

Y C Chang1.   

Abstract

The prognosis of hexacarbon induced polyneuropathy is usually good, though its clinical course after the cessation of exposure has not been described in detail. Eleven patients with moderate to severe n-hexane induced polyneuropathy due to occupational exposure were regularly followed up for a period of four years at the neurological department of the National Taiwan University Hospital. Sensorimotor neuropathy was diagnosed in nine patients and motor neuropathy in two. All were removed from further exposure to n-hexane after aetiological confirmation, but motor disturbance continued to worsen in five cases. Sensory functions were regained earlier than motor functions. All the patients, including one who was tetraplegic and confined to a wheelchair in the early stages, regained their full motor capabilities within one to four years. Three patients with severe neuropathy had residual muscle atrophy in the intrinsic foot and hand muscles. Signs of damage to the central nervous system, including increased tendon reflexes in two patients and leg tightness in six patients, emerged as muscle power was nearing complete recovery. The tightness of the legs gradually disappeared, but muscle cramps of the calves developed and these were still present at the end of follow up. Two patients had mild abnormal colour vision, and the abnormality was still detectable four years later. It is concluded that n-hexane induced neuropathy has a good prognosis, and that spasticity due to damage to the central nervous system is functionally reversible; muscle cramps and dyschromatopsia persist much longer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166555      PMCID: PMC1035212          DOI: 10.1136/oem.47.7.485

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  10 in total

1.  Toxic polyneuropathy of shoe-industry workers. A study of 122 cases.

Authors:  C Cianchetti; G Abbritti; G Perticoni; A Siracusa; F Curradi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

2.  Glue-sniffing neuropathy.

Authors:  R Korobkin; A K Asbury; A J Sumner; S L Nielsen
Journal:  Arch Neurol       Date:  1975-03

3.  Toxic polyneuropathy due to methyl n-butyl ketone. An industrial outbreak.

Authors:  N Allen; J R Mendell; D J Billmaier; R E Fontaine; J O'Neill
Journal:  Arch Neurol       Date:  1975-04

4.  Neurotoxic effects of n-hexane on the human central nervous system: evoked potential abnormalities in n-hexane polyneuropathy.

Authors:  Y C Chang
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

5.  N-hexane-induced electroneurographic changes and early detection of N-hexane intoxication.

Authors:  Y C Chang; P K Yip
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1987-02

6.  n-Hexane polyneuropathy.

Authors:  Y Yamamura
Journal:  Folia Psychiatr Neurol Jpn       Date:  1969

7.  H-reflex behavior in glue (n-hexane) neuropathy.

Authors:  F Bravaccio; A Ammendola; L Barruffo; S Carlomagno
Journal:  Clin Toxicol       Date:  1981-12       Impact factor: 4.467

8.  Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.

Authors:  P S Spencer; H H Schaumburg
Journal:  J Neuropathol Exp Neurol       Date:  1977 Mar-Apr       Impact factor: 3.685

9.  Toxic polyneuropathies after sniffing a glue thinner.

Authors:  H Altenkirch; J Mager; G Stoltenburg; J Helmbrecht
Journal:  J Neurol       Date:  1977-01-13       Impact factor: 4.849

10.  An outbreak of N-hexane induced polyneuropathy among press proofing workers in Taipei.

Authors:  J D Wang; Y C Chang; K P Kao; C C Huang; C C Lin; W Y Yeh
Journal:  Am J Ind Med       Date:  1986       Impact factor: 2.214

  10 in total
  12 in total

1.  An electrophysiological follow up of patients with n-hexane polyneuropathy.

Authors:  Y C Chang
Journal:  Br J Ind Med       Date:  1991-01

2.  Hexane exposure and persistent peripheral neuropathy in automotive technicians.

Authors:  Michael N Bates; Karl Pope; Yuen T So; Sa Liu; Ellen A Eisen; S Katharine Hammond
Journal:  Neurotoxicology       Date:  2019-08-21       Impact factor: 4.294

Review 3.  Neuroprotein Targets of γ-Diketone Metabolites of Aliphatic and Aromatic Solvents That Induce Central-Peripheral Axonopathy.

Authors:  Peter S Spencer
Journal:  Toxicol Pathol       Date:  2020-03-12       Impact factor: 1.902

Review 4.  Toxic Peripheral Neuropathies: Agents and Mechanisms.

Authors:  William M Valentine
Journal:  Toxicol Pathol       Date:  2019-06-10       Impact factor: 1.902

5.  Neurotoxicity induced by exposure to toluene. An electrophysiologic study.

Authors:  C Abbate; C Giorgianni; F Munaò; R Brecciaroli
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

6.  Effect of exposure to 2,5-hexanediol in light or darkness on the retina of albino and pigmented rats. II. Electrophysiology.

Authors:  P Nylén; B Bäckström; M Hagman; A C Johnson; V P Collins; G Höglund
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

7.  Effect of exposure to 2,5-hexanediol in light or darkness on the retina of albino and pigmented rats. I. Morphology.

Authors:  B Bäckström; P Nylén; M Hagman; A C Johnson; G Höglund; V P Collins
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

8.  Occupational neurotoxic diseases in taiwan.

Authors:  Chi-Hung Liu; Chu-Yun Huang; Chin-Chang Huang
Journal:  Saf Health Work       Date:  2012-11-30

9.  Workplace exposures and the risk of amyotrophic lateral sclerosis.

Authors:  Fang Fang; Patricia Quinlan; Weimin Ye; Marie K Barber; David M Umbach; Dale P Sandler; Freya Kamel
Journal:  Environ Health Perspect       Date:  2009-05-11       Impact factor: 9.031

10.  Acquired Color Vision Defects and Hexane Exposure: A Study of San Francisco Bay Area Automotive Mechanics.

Authors:  Stella Beckman; Ellen A Eisen; Michael N Bates; Sa Liu; Gunilla Haegerstrom-Portnoy; S Katharine Hammond
Journal:  Am J Epidemiol       Date:  2016-05-17       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.